Tian Feng, Chen Yun-Dai, Lü Shu-zheng, Song Xian-tao, Yuan Fei, Fang Fang, Li Zhi-an
Department of Cardiology, Beijing Anzhen Hospital of Capital University Medical Science, Beijing 100029, China.
Chin Med J (Engl). 2008 Feb 5;121(3):195-9.
Myocardial perfusion associates with clinical syndromes and prognosis. Adenosine could improve myocardial perfusion of acute myocardial infarction within 6 hours, but few data are available on late perfusion of myocardial infarction (MI). This study aimed at quantitatively evaluating the value of intracoronary adenosine improving myocardial perfusion in late reperfused MI with myocardial contrast echocardiography (MCE).
Twenty-six patients with anterior wall infarcts were divided randomly into 2 groups: adenosine group (n = 12) and normal saline group (n = 14). Their history of myocardial infarction was about 3 - 12 weeks. Adenosine or normal saline was given when the guiding wire crossed the lesion through percutaneous coronary intervention (PCI), then the balloon was dilated and stent (Cypher/Cypher select) was implanted at the lesion. Contrast pulse sequencing MCE with Sonovue contrast via the coronary route was done before PCI and 30 minutes after PCI. Video densitometry and contrast filled-blank area were calculated with the CUSQ off-line software. Heart function and cardiac events were followed up within 30 days.
Perfusion in the segments of the criminal occlusive coronary artery in the adenosine group was better than that in the saline group (5.71 +/- 0.29 vs 4.95 +/- 1.22, P < 0.05). Ischemic myocardial segment was deminished significantly after PCI, but the meliorated area was bigger in the adenosine group than in the saline group ((1.56 +/- 0.60) cm(2) vs (1.02 +/- 0.56) cm(2), P < 0.05). The video densitometry in critical segments was also improved significantly in the adenosine group (5.53 +/- 0.36 vs 5.26 +/- 0.35, P < 0.05). Left ventricular ejection fraction (LVEF) was improved in all patients after PCI, but EF was not significant between the two groups ((67 +/- 6)% vs (62 +/- 7)%, P > 0.05). There was no in-hospital or 30-day major adverse cardiac event (MACE) in the adenosine group but 3 MACE in the saline group in 30 days after PCI.
Adenosine could improve myocardial microvascular perfusion in the late reopening of an occluded infarct related artery (3 to 12 weeks after AMI) and clinical outcome in the follow-up period, and myocardial microvascular perfusion is a powerful predictor of clinical events.
心肌灌注与临床综合征及预后相关。腺苷可改善急性心肌梗死6小时内的心肌灌注,但关于心肌梗死(MI)晚期灌注的数据较少。本研究旨在通过心肌对比超声心动图(MCE)定量评估冠状动脉内腺苷改善晚期再灌注心肌梗死心肌灌注的价值。
26例前壁梗死患者随机分为2组:腺苷组(n = 12)和生理盐水组(n = 14)。他们的心肌梗死病史约为3 - 12周。通过经皮冠状动脉介入治疗(PCI),当导丝穿过病变时给予腺苷或生理盐水,然后扩张球囊并在病变处植入支架(Cypher/Cypher select)。在PCI前和PCI后30分钟通过冠状动脉途径用声诺维造影剂进行对比脉冲序列MCE。用CUSQ离线软件计算视频密度测定法和对比剂充盈-空白面积。随访30天内心功能和心脏事件。
腺苷组罪犯闭塞冠状动脉节段的灌注优于生理盐水组(5.71±0.29对4.95±1.22,P < 0.05)。PCI后缺血心肌节段明显减少,但腺苷组改善面积大于生理盐水组((1.56±0.60)cm²对(1.02±0.56)cm²,P < 0.05)。腺苷组关键节段的视频密度测定法也有显著改善(5.53±0.36对5.26±0.35,P < 0.05)。PCI后所有患者左心室射血分数(LVEF)均有改善,但两组间EF无显著差异((67±6)%对(62±7)%,P > 0.05)。腺苷组在PCI后30天内无院内或30天主要不良心脏事件(MACE),而生理盐水组有3例MACE。
腺苷可改善梗死相关动脉闭塞晚期再通(急性心肌梗死后3至12周)时的心肌微血管灌注及随访期临床结局,且心肌微血管灌注是临床事件的有力预测指标。